Estrogen replacement therapy at menopause

Preview

Bone loss and cardiovascular disease are the most important complications of menopause. Because estrogen has been shown to prevent bone loss and also reduce fracture rates in menopausal women, the authors recommend early replacement therapy. They also examine evidence that estrogen replacement may offer these women protection from cardiovascular disease and discuss the risks of estrogen-related endometrial and breast cancer.

Additional information

Notes on contributors

George T. Griffing

George T. Griffing, MD Dr Griffing is professor of medicine and director, division of endocrinology, diabetes, and metabolism, University of Missouri—Columbia School of Medicine. His interests include steroid metabolism and diseases of the adrenal gland and gonads.

Susan H. Allen

Susan H. Allen, PhD, MD Dr Allen is associate professor of medicine and member, division of endocrinology, diabetes, and metabolism, University of Missouri—Columbia School of Medicine, and director of the university's bone clinic. She has a long-standing interest in metabolic bone disease and osteoporosis.